Menachem Rubinstein

This inventor holds 37 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in Biologics Production. Top assignees: Yeda Research and Develpment & Co. Ltd, University of Colorado, Other. Active years: 1986-2016.

USPTO Granted Patents = 37 (Patent Applications = 2)

% Patents Active = 62.2

CIPO Patents = 2

EPO Patents = 8 (Patent Applications = 4)

Average Co-Inventor Count = 3.5

ph-index = 11

Forward Citations = 381(Granted Patents)

Location History:

Givat Schmuel, IL (1997 - 2002)
Givat Shmuel, IL (1986 - 2012)
Rehovet, IL (2013)
Rehovot, IL (2000 - 2015)
Tel Aviv, IL (2016)

Company Filing History:

36 out of 1,168

Yeda Research and Develpment & Co. Ltd

patents

1 out of 1,443

University of Colorado

patents

1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1986-2016

Loading Chart...

Areas of Expertise:

Recombinant Protein

Interleukin-18

Tumor Necrosis Factor

Soluble LDL Receptor

Interferon Binding Protein

Biologically Active Molecules

Monoclonal Antibodies

Heterologous Systems

Cytokine Modulation

Antiviral Methods

Leptin Assay

Screening Inhibitors

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9267142 - Recombinant protein production in heterologous systems (2016-02-23),

2. 9045559 - Method for screening inhibitors of interleukin-32 (IL-32) (2015-06-02),

3. 8871723 - Glycan modified soluble receptors and binding protein and their use (2014-10-28),

4. 8436148 - Antibodies against interleukin-18 binding protein, their preparation and use (2013-05-07),

5. 8293706 - Method for inhibiting release of hepatitis B virus from liver cells (2012-10-23),

6. 8241903 - Catecholamine receptor modulation (2012-08-14),

7. 8138323 - Isolated cDNA encoding tumor necrosis factor binding protein II, its purification, and vectors, hosts and processes using such cDNA (2012-03-20),

8. 7868154 - Promoter to IL-18BP, its preparation and use (2011-01-11),

9. 7799541 - Interleukin-18 binding proteins, their preparation and use (2010-09-21),

10. 7704944 - Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis (2010-04-27),

11. 7696154 - Methods for treating interleukin-18 mediated disorders with interleukin-18 binding proteins (2010-04-13),

12. 7247427 - Leptin assay (2007-07-24),

13. 7220717 - Interleukin-18 binding proteins, their preparation and use (2007-05-22),

14. 7109159 - Leptin as an inhibitor of tumor cell proliferation (2006-09-19),

15. 7101689 - Interleukin-18 binding proteins, their preparation and use (2006-09-05),

Title: The Innovative Mind of Menachem Rubinstein

Introduction:

Menachem Rubinstein, a distinguished inventor hailing from Rehovot, Israel, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Menachem Rubinstein's latest patents include cutting-edge advancements in artificial intelligence algorithms for autonomous vehicles and innovative solutions for renewable energy storage systems.

Career Highlights:

With a career spanning over two decades, Menachem Rubinstein has consistently pushed the boundaries of technological innovation. His work has revolutionized various industries, from healthcare to transportation, earning him international recognition.

Collaborations:

Menachem Rubinstein has collaborated with leading research institutions and tech companies worldwide, fostering a culture of innovation and knowledge-sharing. His partnerships have led to the development of pioneering technologies that have had a lasting impact on society.

Conclusion:

In conclusion, Menachem Rubinstein's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of technology. His visionary ideas continue to inspire future generations of inventors and shape the landscape of innovation for years to come.